Rush University Banner Rush University Rush University Medical Center Contact Us
Rush University Banner
Search
GME
Career Opportunities at Rush University > Rush University > Pharmacy Residency Program
Careers at Rush

Pharmacy Residency Program

Job Title: Pharmacy Residency Program
Position Requisition #:

Position Description:

PGY1 Pharmacy Residency Program

About the PGY1 Program
Meet our PGY1 Residents
How to Apply for our PGY1 Program
 

All Resident Responsibilities/Benefits

On-call Responsibilities
Staffing Responsibilities
Other Activities
Benefits
 

PGY2 Pharmacy Residency Programs

Meet our PGY2 Residents
Critical Care Residency
Solid Organ Transplant Residency
Hematology/Oncology Residency
 

Meet the Preceptors

Rush PGY1 Pharmacy Residency Program

Welcome from the PGY1 Director

Thank you for your interest in Rush University Medical Center's post-graduate year one (PGY1) residency.

Our residency training program is directed toward developing competent, well-rounded, patient-oriented pharmacists. It consists of rotations focusing on clinical practice, as well as experience which provides insight into pharmaceutical care management. An important dimension of our program, however, is the opportunity for residents to effect meaningful change in one of the largest and most progressive academic health science centers in the United States. The depth and scope of clinical services at Rush, as well as our experienced preceptors, represent our most significant strengths.

At Rush, our primary concern is optimizing each resident's personal professional development. This is accomplished through the design of specific programs to meet your career objectives. Residents are given patient-care responsibilities and the necessary autonomy and authority to meet them, yet a preceptor is always available to provide support as needed. You are encouraged to effect change and to initiate new services. The program also provides ample opportunities for improving both written and verbal communication skills.

Again, we appreciate your interest in the Rush PGY1 Residency Program. For questions, feel free to call me at (312) 942-2108 or by e-mail at nora_flint@rush.edu.

Sincerely,

Nora Flint, PharmD, BCPS, FASHP
Director, PGY1 Residency Program

Associate Corporate Director
Department of Pharmacy
Rush University Medical Center
1653 W. Congress Parkway
Chicago, IL 60612
(312) 942-2108
nora_flint@rush.edu

Philosophy

The PGY1 residency program provides in-depth professional, patient directed training and experience at the post-graduate level. It offers the resident the opportunity and stimulus to develop, to the highest degree attainable, his/her professional expertise as a clinical practitioner, emphasizing skills required to optimally deliver pharmaceutical care. In addition, the resident will be exposed to the management of a pharmacy department and gain insight into the responsibility one has toward accepting leadership and making a contribution back to the profession of pharmacy.

A basic tenet of our philosophy of training is that while being experientially based and focused, the residency program does not exist exclusively to provide service to the department or hospital per se. All service components of the department's program can function in the absence of residents' participation. Residents are critical to our department's vitality and professional development.

The residents are expected to contribute substantially to the achievement of the department's mission through active and innovative participation in assigned projects which also meet residency training objectives. We do not believe that these are mutually exclusive.

An overarching goal of the residency training program is the development of a personal philosophy of practice which will facilitate the provision of pharmaceutical care in their respective careers. This is guided by critical thought and patient advocacy in all aspects of drug therapy.

The residency program is designed to comply with the officially published accreditation standards of the American Society of Health-System Pharmacists (ASHP). Efforts to provide the specific training and guidance that is optimal for a particular resident are extended whenever appropriate, feasible and mutually agreed upon by the resident, Program Director and Pharmacy Director. A demonstrable desire to learn, a sincere career commitment to pharmacy practice, and a dedication to fully meeting all objectives and requirements of the program and the department are basic expectations of all residents.

The PGY1 residency program is designed and structured to provide the organized health care practice community and the pharmacy profession with knowledgeable, creative and resourceful practitioners who will be able to fulfill a range of pharmaceutical care responsibilities.

Residents are expected to actively and directly participate in a balanced array of clinical and practice management activities during required assignments. This participation may take the form of weekend/holiday presence and/or projects directly related to the provision of patient care services and/or participation in Department of Pharmacy programs.

Preceptors are responsible for assuring that this participation provides the resident with a high degree of project and/or patient specific case management involvement. Projects are assigned or selected with the dual purpose of benefit to patients and learning/experiential value to the resident. Appropriate guidance and instruction is provided by the preceptor while the resident is participating in such activities, as well as during learning experiences such as lectures, conferences, in-services and seminars. Other relevant activities include departmental evaluation, planning, and clinical service implementation efforts, and interdepartmental activities.

Mission and Goals

The primary mission of the PGY1 residency program is to train the resident to be a competent, patient-oriented pharmacist who can optimally contribute to a pharmacy department and to a clinical practice that embraces the concept of pharmaceutical care.

PGY1 Purpose Statement

Pharmacists completing the PGY1 residency program at Rush will be competent practitioners able to provide direct patient care in a variety of inpatient clinical and practice management settings such as a clinical staff pharmacist role or the pursuit of additional training in a PGY2 residency program.

Meet the PGY1 Residents

Photo caption: Back Row: Tristan O'Driscoll, Brent Bastian, Eris Tollkuci,Ron Kendall
Front Row: Melissa Kocek, Yvonne Duong, Marissa Janusek, Bridget Hoy

PGY1 Residents  Email address
Brent Bastian, PharmD brent_bastian@rush.edu
Yvonne Duong, PharmD yvonne_duong@rush.edu
Bridget Hoy, PharmD bridget_hoy@rush.edu
Marissa Janusek, PharmD marissa_janusek@rush.edu
Ron Kendall, PharmD (Chief Resident) ron_kendall@rush.edu
Melissa Kocek, PharmD melissa_kocek@rush.edu
Tristan O'Driscoll, PharmD
tristan_o'driscoll@rush.edu
Eris Tollkuci, PharmD eris_tollkuci@rush.edu

How to Apply

We take eight (8) post-graduate year 1 (PGY1) residents every year. The application deadline is January 1, and is now online through PhORCAS.

The following must be submitted when applying through PhORCAS:

  • Letter of intent
  • Official transcripts of all pharmacy education
  • Current resume or curriculum vitae
  • Three references
  • Interest assessment form (PGY1 only)

For PGY1 applicants, one reference should be from a faculty member in your professional degree program. Other references should be from practicing pharmacists with whom you have had patient care/rotation experience.

If you are interested in our program, please log onto PhORCAS (portal.phorcas.org) and submit your application no later than January 1. We require that all applicants to our program be in the process of completing educational requirements for or have already graduated with a PharmD Degree from an ACPE accredited college of pharmacy and be eligible for pharmacy licensure in Illinois. Moreover, you must be enrolled in the American Society of Health System Pharmacists' Residency Matching Program.

In our mutual interests, we require an on-site interview at Rush to allow for a tour of the facility and a personal introduction to our preceptors. As there are usually many more applicants than we have time to interview, the sooner your materials are complete, the better. Once your file is complete and we have a chance to review your materials, you will be notified by email after January 1st.  Selected applicants will be contacted for an on-site interview.

For additional residency program information, stop by the Rush University Medical Center showcase at the ASHP Midyear Clinical Meeting. 

 

 

 

 

 

 

Required PGY1 Rotations

Rush has been involved in pharmacy residency training for over 30 years. Some of the components of the residency at Rush are as follows:

Required Rotations (2013-2014)

  1. Internal medicine
  2. Critical care
  3. Practice management
  4. Pediatrics
  5. Infectious disease
  6. Formulary Management
  7. Immunology (Hematology/Oncology, or Solid Organ Transplant)

Elective rotations (2013-2014)

  1. Bone marrow transplant
  2. Inpatient anticoagulation
  3. Investigational drugs
  4. Nutrition
  5. Medication Safety
  6. Ambulatory Care

All Pharmacy Resident Responsibilities

24-Hour On-Call Service (in house)

All PGY1 and PGY2 residents will be expected to take overnight call in the medical center approximately one out of every fourteen nights. Responsibilities during call include, but are not limited to, pharmacokinetic drug monitoring, answering clinical questions, participation in code blue emergencies (adult and pediatric), approval of restricted antimicrobials, and participation in acute stroke emergencies. On call responsibilities are 7 a.m. to 7 a.m. the following morning. This on call program is in compliance with the current ASHP duty hour regulations.

Staffing

Staffing responsibilities include one out of every four weekends of clinical staffing for both PGY1 and PGY2 residents.

Other Activities

  1. Weekly resident conference (patient case, journal club, or disease management lectures)
  2. Resident research project
  3. Longitudinal projects in quality assurance, policy/guideline development, drug use evaluation, and P+T Committee
  4. Didactic lectures to pharmacy technicians, pharmacy students and other healthcare professionals

Rush Benefits

Rush PGY2 Pharmacy Residency Programs

Meet the PGY2 Residents

 

Photo caption: From the left: Krystina Geiger, Adam Diamond, Justin Wrin, Adam Linstedt, Priya Shahm Jilan Kubusek

Resident Name Email Address Specialty
Priya Shah, PharmD priya_shah@rush.edu Critical Care
Adam Diamond, PharmD adam_diamond@rush.edu Solid Organ Transplant
Jilan Kubusek, PharmD, BCPS jilan_kubusek@rush.edu Hematology/Oncology
Krystina Geiger, PharmD krystina_geiger@rush.edu Midwestern-Critical Care
Adam Linstedt, PharmD adam_linstedt@rush.edu Midwestern-Critical Care
Justin Wrin, PharmD justin_wrin@rush.edu Midwestern-Infectious Disease

Rush PGY2 Critical Care Residency Program

The Critical Care PGY2 Residency Program at Rush is a one year residency established to provide specialty training for residents interested in critical care. Currently, the program has one PGY2 critical care resident working in collaboration with two PGY2 critical care residents from Midwestern University. The program is accredited by American Society of Health-System Pharmacists (ASHP).

Purpose Statement

The PGY2 Critical Care Residency at Rush University Medical Center provides the resident with a well-rounded experience in the medical, cardiac, surgical and neuroscience intensive care units and the emergency department. The program is designed to develop the resident's clinical expertise in the care of critically ill patients through a variety of core and elective rotations. Additionally, residents will have opportunities to gain experience in teaching, research and quality improvement. The primary goal of the program is to develop independent clinicians able to care for critically ill patients in an academic medical setting.

Patient Care Experience

The resident will have the opportunity to participate in multidisciplinary care of critically ill patients in an academic teaching environment. The resident will practice in a state-of-the-art, new critical care facility which will expand upon the current 21-bed medical intensive care unit, 28-bed cardiac intensive care unit, 22-bed surgical intensive care unit , 28-bed neuroscience intensive care unit, and a 56-bed emergency department.

 

 

 

 

 

 

Required PGY2 Rotations

Required Rotations (2013-2014)

  1. Medical ICU (4 weeks)
  2. Cardiac ICU (4 weeks)
  3. Surgical ICU (4 weeks)
  4. Neuroscience ICU (4 weeks)
  5. Emergency Medicine (4 weeks)
  6. Infectious disease (4 weeks)
  7. Research (~4 weeks)

Elective Rotations (2013-2014)

  1. Toxicology
  2. Trauma
  3. Burn
  4. Pediatric ICU
  5. Neonatal ICU
  6. Nutrition support
  7. Hematology/oncology
  8. Transplant

Research Experience

The PGY2 resident will be expected to complete a longitudinal research project in collaboration with an experienced preceptor. The project will be of the resident's choice and involve a critical care concept. The project will be presented at the Great Lakes Residency Conference in April. One month of the year will be dedicated for research activities.

Teaching Experience

The PGY2 resident will serve as a preceptor for Doctor of Pharmacy students enrolled at Midwestern University, Chicago State, University of Illinois at Chicago and Roosevelt University. He/she will also lead small group discussions with pharmacy students and PGY1 residents. There will be opportunities to participate in the didactic education at Midwestern University or Rush University Graduate School.

How To Apply

One PGY2 resident is taken every year. The application deadline is January 1st and is now available online through PhORCAS. 

For more information about the Rush Critical Care PGY2 residency program, please contact:

Kimberly Ackerbauer, PharmD, BCPS
Director, PGY2 Critical Care Residency Program
kimberly_ackerbauer@rush.edu(312) 947-1081

For more information on the PGY2 Critical Care Residency at Midwestern University (Practice Site - Rush University Medical Center), visit Midwestern University Chicago College of Pharmacy's website for the PGY2 Critical Care Residency.

Rush PGY2 Solid Organ Transplant Program

The Solid Organ Transplant PGY-2 Pharmacy Residency Program at Rush University Medical Center (RUMC) is a one-year residency established to provide specialty training for residents interested in organ transplantation. The program offers multidisciplinary and comprehensive care of recipients of heart, liver, kidney, and kidney/pancreas transplants of a diverse patient population. Following completion of this program, the resident will have developed the skills necessary for the competent, compassionate, and evidence-based care of transplant recipients. This is currently the second year of the PGY-2 Solid Organ Transplant program and it is in candidate status for accreditation by the American Society of Health-System Pharmacists (ASHP)

Solid Organ Transplant Mission Statement

The PGY2 Solid Organ Transplant Residency at Rush University Medical Center is intended to develop the resident's clinical expertise in immunology and solid organ transplant and facilitate the development of clinical skills related to the pre-transplant assessment, perioperative care and long term management of solid organ transplant recipients. The primary goal of the program is to develop independent clinicians able to provide patient-centered, pharmaceutical care in this specialty. The resident will work as a member of a multidisciplinary team and provide direct patient care through daily clinical activities, participation in research and performance improvement projects.

Patient Care Experience

RUMC performs approximately 50 liver, 80 kidney, 5 kidney/pancreas and 10 heart transplants per year. The resident will have the opportunity to participate in the multidisciplinary care of these patients. The resident will serve as an integral member of the rounding team by participating in medication therapy management, answering key clinical questions and serving as a resource to the healthcare team. Our outpatient transplant clinics offer the resident longitudinal experience in transplant care.

 

 

 

 

 

 

Required Rotations (2013-2014)

  1. Abdominal Transplant (8 weeks)
  2. Heart Failure/Heart Transplant (4 weeks)
  3. Surgical ICU (4 weeks)
  4. Infectious disease (4 weeks)
  5. Bone Marrow Transplant (4 weeks)
  6. Research (~4 weeks)

Elective Rotations (2013-2014)

  1. Transplant Hepatology (4 weeks)
  2. Transplant Nephrology (4 weeks)
  3. Outpatient Transplant Clinic (longitudinal)
  4. Pediatriac Transplant at Laurie Children's Hospital (4 weeks)
  5. Cardiac Intensive Care Unit (4 weeks)

Research Experience

The PGY2 resident will be expected to complete a longitudinal research project in collaboration with an experienced preceptor and clinician stakeholders. The project will be of the resident's choice and involve a solid organ transplant concept. The project will be presented at the American Transplant Congress meeting or at the Great Lakes Pharmacy Residency Conference. One month of the year will be dedicated for research activities.

Teaching Experience

RUMC is actively involved in experiential coursework and receives students from Midwestern University, Chicago State, University of Illinois at Chicago, and Roosevelt University. The resident can serve as a preceptor to develop hands on teaching skills. He/she will also lead small group discussions with pharmacy students and PGY1 residents. There will be opportunities to participate in the didactic education at Midwestern University

How To Apply

One PGY2 resident is taken every year. The application deadline is January 1st and is now available online through PhORCAS. 

For more information about the Rush Solid Organ Transplant PGY2 residency program, please contact:

Nicole Alvey, PharmD, BCPS
Director, PGY2 Solid Organ Transplant
nicole_alvey@rush.edu
(312) 942-2024

 

RUSH PGY2 Hematology/Oncology Residency Program

The Oncology PGY2 Residency Program at Rush is a one-year residency established to provide specialty training for residents interested in hematology, oncology and stem cell transplant. Currently, the program has one PGY2 oncology resident and is in it's second year. The program is in candidate status for accreditation by the American Society of Health-System Pharmacists (ASHP)

PGY2 Oncology Purpose Statement

The PGY2 Oncology Residency at Rush University Medical Center provides the resident with a well-rounded experience in acute and ambulatory care hematology, oncology and stem cell transplant. The program is designed to develop the resident's clinical expertise in the care of hematology/oncology patients through a variety of core and elective rotations. Additionally, residents will have opportunities to gain experience in teaching, research, oncology informatics and quality improvement. The primary goal of this program is to develop independent clinicians able to care for acute and ambulatory care patients as part of hematology, oncology and stem cell therapy interdisciplinary teams. Finally, the resident will be prepared for board certification in oncology pharmacy.

Patient Care Experience

The resident will have the opportunity to participate in multidisciplinary care of hematology/oncology patients in an academic teaching environment. The resident will practice in a state-of-the-art, new hematology/oncology facility which has a capacity of 64-beds, 32-beds which are designated for hematology/stem cell transplant.

The Rush University Cancer Center programs have received approval by the Commission on Cancer of the American College of Surgeons as an Academic Comprehensive Cancer Program. The new outpatient facility at Rush opened in January 2012 and has 56 infusion stations that treat approximately 80-100 patients per day. 

Required Rotations (2013-2014)

  1. Inpatient Hematology/Oncology (6 weeks)
  2. Stem Cell Transplant (4-6 weeks)
  3. Infusion Center Pharmacy/Investigational Drug Service (4 weeks)
  4. Hematology Consults (4 weeks)
  5. Pediatric Hematology/Oncology (4 weeks)
  6. Research (~4 weeks)
  7. Outpatient clinics (4 weeks)
  8. Longitudinal clinics (~6 months each)

Elective Rotations (2013-2014) (all rotations 2-4 weeks)

  1. Gynecology/Oncology
  2. Infectious Diseases
  3. Pain and Palliative Care/Hospice
  4. Oncology Informatics
  5. Nutrition support

Research Experience

The PGY2 resident will be expected to complete a longitudinal research project in collaboration with an experienced preceptor. The project will be of the resident's choice and involve a hematology/oncology/stem cell transplant concept. The project will be presented at the Hematology/Oncology Pharmacy Association (HOPA) Conference in March/April. One month of the year will be dedicated for research activities.

Teaching Experience

The PGY2 resident will serve as a preceptor for Doctor of Pharmacy students enrolled at Midwestern University, Chicago State, University of Illinois at Chicago and Roosevelt University. He/she will also lead small group discussions with pharmacy students and PGY1 residents. There will be opportunities to participate in the didactic education at Midwestern University or Rush University Graduate School.

How To Apply

One PGY2 resident is taken every year. The application deadline is January 1st and is now available online through PhORCAS. 

For more information about the Rush Hematology/Oncology PGY2 residency program, please contact:

Kathryn Schultz, PharmD, BCPS, BCOP
Director, PGY2 Hematology/Oncology
kathryn_schultz@rush.edu
(312) 942-6818

For more information on the PGY2 Infectious Disease Residency at Midwestern University (Practice Site - Rush University Medical Center), visit Midwestern University Chicago College of Pharmacy's website for the PGY2 Infectious Disease Residency.

Meet the Preceptors 

Kimberly Ackerbauer PharmD, BCPS
Director, PGY2 Critical Care
Clinical Specialist, Critical Care
Nicole Alvey, PharmD, BCPS
Director, PGY2-Solid Organ Transplant
Clinical Specialist, Transplant
Sally Arif, PharmD, BCPS, AQ-C
Clinical Specialist, Cardiology
Faculty, Midwestern University
Kimberly Berger, PharmD, BCPS
Clinical Specialist, Critical Care
Danielle Bishop, PharmD, BCPP
Clinical Specialist, Psychiatry

Marissa Brokhof, PharmD, BCPS
Clinical Specialist, Transplant
Rebecca Castner, PharmD, BCPS
Clinical Specialist, Ambulatory Care
Faculty, Chicago State University
 
Peggy Choye, PharmD, BCPS
Clinical Specialist, Internal Mediciine
Kevin Colgan, RPh, MA
Corporate Director of Pharmacy
Chris Crank, PharmD, BCPS, AQ-ID
Associate Director of Clinical Services
Clinical Specialist, Infectious Disease
Lisa DiGrazia, PharmD
Clinical Specialist, Heme/Onc
Kirk Dennis, PharmD, BCPS
Clinical Specialist, Internal Medicine

Joshua DeMott, PharmD, BCPS
Clinical Specialist, Critical Care
Nora Flint, PharmD, BCPS
Director, PGY1 Program
Associate Corporate Director of Pharmacy
Monika Gil, PharmD, BCPS
Clinical Specialist, Transplant

Jennifer Geyston, PharmD
Clinical Specialist, Transplant
Payal Gurnani, PharmD, BCPS
Clinical Specialist, Critical Care
 
Amy Hanson, PharmD, BCPS
Clinical Specialist, Infectious Disease
 
Deborah Hass, PharmD, BCOP
Clinical Specialist, Heme/Onc
Faculty, Midwestern University
Nina Huynh, PharmD, BCPS
Clincial Specialist, Anticoagulation
Ann Jankiewicz, PharmD, BCPS Clinical Specialist, Medication Safety
 
Julie Jun, PharmD, BCPS
Clinical Specialist, Internal Medicine
Nicolas Panos, PharmD, BCPS
Clinical Specialist, Critical Care
Gourang Patel, PharmD, MSc, BCPS
Clinical Specialist, Critical Care
 
Gary D. Peksa, PharmD, BCPS
Clinical Specialist, Critical Care
Gigi Rechner, PharmD, BCPS
Clinical Specialist, Critical Care
Kathryn Schultz, PharmD, BCOP
Director, PGY2 Heme/Onc
Clinical Specialist, Heme/Onc
Beth Shields, PharmD
Clinical Specialist, Pediatrics
Associate Director, Operations
 
Kate Starosta, PharmD, BCPS,
Clinical Specialist, Critical Care
 
Sheila Wang, PharmD, BCPS, AQ-ID
Clinical Specialist, Infectious Disease
Faculty, Midwestern University
Roger Wilcox, PharmD, BCPS
Clinical Specialist, Pediatrics
Not Pictured
Laura Geswein, PharmD, BCPS, Clinical Speciailst, Heme/Onc and Internal Medicine
Yana Labinov, PharmD, BCPS, Clinical Specialist, Internal Medicine, Faculty, Roosevelt University
Marketa Marvanova, Pharm.D., BCPS, Clinical Specialist, Neurology, Faculty, Chicago State University
Matt Nelson, PharmD, BCPS, Clinical Specialist, Internal Medicine, Faculty, Roosevelt University
Michael Yannell, PharmD, BCPS, Clinical Specialist, Heme/Onc and Internal Medicine
 

 

Additional Information:


Job Contact Information
Nora B. Flint, PharmD, BCPS
Phone: (312) 942-2108
E-mail: nora_flint@rush.edu





Rush Medical College | College of Nursing | Graduate College | College of Health Sciences | Library | GME
CME | Calendar of Events | Web Privacy Statement | Accessibility Statement | Students with Disabilities | Site Map
Students | Faculty | Researchers | Alumni | Residents & Fellows

© Rush University, Chicago, Illinois